Both E2 and 3β-diol antagonize DUX4 transcriptional activity, counteract its toxicity, reduce DUX4-induced muscle fibrosis, and improve muscle regeneration, providing valuable insights into the function of these hormones in human FSHD pathology. This evidence concerns the gene DUX4 and Facioscapulohumeral dystrophy.